Corcept Therapeutics Incorporated

NASDAQ:CORT

73.4 (USD) • At close June 30, 2025
Bedrijfsnaam Corcept Therapeutics Incorporated
Symbool CORT
Munteenheid USD
Prijs 73.4
Beurswaarde 7,783,703,000
Dividendpercentage 0%
52-weken bereik 29.42 - 117.33
Industrie Biotechnology
Sector Healthcare
CEO Dr. Joseph K. Belanoff M.D.
Website https://www.corcept.com

An error occurred while fetching data.

Over Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have

Vergelijkbare Aandelen

AbCellera Biologics Inc. logo

AbCellera Biologics Inc.

ABCL

3.43 USD

Arvinas, Inc. logo

Arvinas, Inc.

ARVN

7.36 USD

Fate Therapeutics, Inc. logo

Fate Therapeutics, Inc.

FATE

1.12 USD

Canopy Growth Corporation logo

Canopy Growth Corporation

CGC

1.22 USD

Amicus Therapeutics, Inc. logo

Amicus Therapeutics, Inc.

FOLD

5.73 USD

Tilray Brands, Inc. logo

Tilray Brands, Inc.

TLRY

0.414 USD

PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc.

PTCT

48.84 USD

Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

BEAM

17.01 USD

Allscripts Healthcare Solutions, Inc. logo

Allscripts Healthcare Solutions, Inc.

MDRX

9.25 USD

Alignment Healthcare, Inc. logo

Alignment Healthcare, Inc.

ALHC

14 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)